FTY720 increases paclitaxel efficacy in cisplatin-resistant oral squamous cell carcinoma.

Lizeth Andrea Torres TorresGabriel SilvaJovelina Samara Ferreira AlvesTatiane Resende UshidaJulia PotenzaCristiana Bernadelli GarciaLucas Oliveira SousaNorberto Peporine LopesLuciana Oliveira AlmeidaAndréia Machado Leopoldino

Published in: Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology (2023)

FTY720 sensitizes cisplatin-resistant oral squamous cell carcinoma cells for paclitaxel.

Keyphrases

squamous cell
oxidative stress